Retroviral transformation has been associated with pro-proliferative oncogenic signaling in human cells. The current study demonstrates that transduction of human breast carcinoma cells (MDA-MB231) with LXSN and QCXIP retroviral vectors causes significant increases in growth rate, clonogenic fraction, and aldehyde dehydrogenase-1 positive cells (ALDH1+), which is associated with increased steady-state levels of cancer stem cell populations. Furthermore, this retroviral-induced enhancement of cancer cell growth in vitro was also accompanied by a significant increase in xenograft tumor growth rate in vivo. The retroviral induced increases in cancer cell growth rate were partially inhibited by treatment with 100 U/ml polyethylene glycol-conjugated-(PEG)-superoxide dismutase and/or PEG-catalase. These results show that retroviral infection of MDA-MB231 human breast cancer cells is capable of enhancing cell proliferation and cancer stem cell populations as well as suggesting that modulation of reactive oxygen species-induced pro-survival signaling pathways may be involved in these effects.
Journal article
Retroviral-infection increases tumorigenic potential of MDA-MB-231 breast carcinoma cells by expanding an aldehyde dehydrogenase (ALDH1) positive stem-cell like population
Redox Biology, Vol.2, pp.847-854
01/01/2014
DOI: 10.1016/j.redox.2014.06.006
PMCID: PMC4085353
PMID: 25009786
Abstract
Details
- Title: Subtitle
- Retroviral-infection increases tumorigenic potential of MDA-MB-231 breast carcinoma cells by expanding an aldehyde dehydrogenase (ALDH1) positive stem-cell like population
- Creators
- Lauren J Wegman-Points - University of IowaMelissa L.T. Teoh-Fitzgerald - University of IowaGaowei Mao - University of IowaYueming Zhu - University of IowaMelissa A Fath - University of IowaDouglas R Spitz - University of IowaFrederick E Domann - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Redox Biology, Vol.2, pp.847-854
- DOI
- 10.1016/j.redox.2014.06.006
- PMID
- 25009786
- PMCID
- PMC4085353
- NLM abbreviation
- Redox Biol
- ISSN
- 2213-2317
- Copyright
- Copyright © 2014 The Authors. Published by Elsevier B.V.
- Grant note
- Grant support R01CA133114/CA/NCI NIH HHS/United States P30 ES005605/ES/NIEHS NIH HHS/United States R01CA115438/CA/NCI NIH HHS/United States R01 CA133114/CA/NCI NIH HHS/United States R01CA182804/CA/NCI NIH HHS/United States P30 CA086862/CA/NCI NIH HHS/United States R01 CA115438/CA/NCI NIH HHS/United States P30CA086862/CA/NCI NIH HHS/United States T32 CA078586/CA/NCI NIH HHS/United States T32CA078586/CA/NCI NIH HHS/United States R01 CA182804/CA/NCI NIH HHS/United States
- Language
- English
- Date published
- 01/01/2014
- Academic Unit
- Pathology; Surgery; Carver College of Medicine; Radiation Oncology; Health, Sport, and Human Physiology
- Record Identifier
- 9983557343802771
Metrics
126 File views/ downloads
52 Record Views